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ABSTRACTS 
It is well established that the choroid plexus is a major site 
of c. s • f. production and for regula Hng the composl tion of the c. s . f. 
The ill situ isolated choroid plexus preparation provides a unique 
system with which to study the role of the choroid plexus in the 
regulation of ion transport from blood to c. s .. f. and vice versa .. 
The concentration of lithium in the interstitial fluid of brain is known 
to affect the function of the brain. Measurement of the c. s • f. 
concentration of lithium serves as a gross reflection of the lithium 
concentration in the extracellular fluld of the C. N. S. The role of 
the choroid plexus in regulation of lithium concentration in the 
c.s.f. with and without alterations in c.s.f. and plasma levels of 
this ion was studied. Tne change in concentration of lithium in 
the chamber fluid was about 0 ~ 58 m-equiv/l. for each 1 m-equiv/L 
change in plasma concentration of lithium in response to the 
infusion of a 154 m~f LiCl solution. The lithium concentration in 
chamber fluid was maintained at 53% to 60% of plasma levels when 
the plasma lithium concentrations varied over the therapeutic and 
the toxic range in man. The concentration of lithium reached a 
steady state in plasma and in c. s.f. at about 90 min after the start 
of a constant. intravenous infusion of LtCl solution. This shows 
that the slow onset of action of lithium in the treatment of manic 
depression is not due to the Inabilit'"j' of lithium to cross the 
blood-c. s. f. barrier. The concentration of lithium in the chamber 
fluid decreased during the 30 min collection period when either 
low or hlgh lithium in artificial c. s. f .. was added to the chamber. 
The magnitude of the decrease is independent of the direction of 
the gradient between plasma and c. s. f. over the range studied. 
This indicates that dilution by newly formed fluid is a major 
factor in reducing the concentration of lithium in the chamber. It 
is reduced secondarily by passive diffusion. The change in the 
concentration of potassium on the c. s. f. side of the choroid 
plexus induced appropriate alterations in the new c. s. f. potassium 
to bring the concentration of potassium in the chamber fluid toward 
a normal value. Lithium appears to be transported by the same 
system that regulates c.s.f. potassIum. However, the system 
is much more selective for potassium. These results support the 
concept that lithium is transported to a limited extent by sodium 
pumps and also diffuses passively. 
The mechanisms underlying the therapeutic usefulness of 
lithium in mania are not known. The in situ isolated choroid plexus 
in cats was used to investigate the effect of varying the lithium 
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concentration in plasma and 1n c. s. f. on the concentration ~"jf electro-
lytes in the c. s.f. The concentration of magnesium in plasma was 
2.7 m-equiv/l. or more, Ylhlle chamber fluid magnesium was not 
. 22 
affected. The chamber fluid to plasma ratio of Na is greater than 
unity after a 90 mIn infusion of 22 NaCl solution. The total amount 
of 22Na in the chamber fluid significantly increased when lithium 
(1.5 m-equiv/l.) or high-potassium (6" 6 m-eql1iv/l.) artificia.l c. s. f. 
was added to the chamber; there is no difference in 22Na activity 
betw'een the control and the experimental group in which SO tJ.l of 
normal artificial c. s. f. was added to the chamber. Ouabain 
(10-3 M) significantly inhibited the stimulatory effect of lithium or 
22 high-potassium on the rate of Na transport from blood to c. s .. f. 
22 
and al so reduced the rate of c. s . f. secretion. The entry of Na 
into the chamber was not affected by plasma lithium levels correspon-
ding to the subtherapeutic to therap.eutic levels in man. The present 
experiments suggest that lithium is transported by systems that 
normally transport sodium into the c.s.f. to produce the fluid and 
transport potassium out of c. s. f. in exchange for sodium. There 
is also a significant diffusional component. 
vi 
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PART ONE 
TIIE REGULATION OF CEREBROSPINAL FLUID LITI-IIUM BY TIm 
ISOLATED IN SITU GIOROID PLEXUS OF TIlE CAT 
INTRODUCTION 
Cade (1949) reported that lithium salts given to ten manic pa-
tients resulted in uniform improvement. Since then, investigators 
have extensively studied the phannacological and biological activity 
of lithium. If serum lithitnn is to be maintained at levels suffi-
cient to provide therapeutic concentrations in the C.N.S. for the 
treatment of manic-depression and other mental illness, information 
on the l~lation between plasma levels and c.s.f. concentrations of 
this ion is necessary. Schou (1958) reported that lithium passes in-
to a variety of tissues from the blood and that the entry rates vary 
in different tissues and organs; the mechanisms governing its entry 
into the C.N.S. were not defined. Because little definitive infor-
mation is available concerning the entry of lithium into the C.N.S. 
data concerning lithitnn movements across other biological membranes 
are of interest. Experiments on lithiun flux in frog skin, frog mus-
cle, erythrocytes and mammalian nerve tissue, i.e., non-myelinated C-
fibers, have been performed. The flux of lithium into frog ml~cle is 
similar to the passive jnflux rate of sodium (Keynes & Swan, 1959). 
Also, lithium and soditnn permeabilities are of the same order of mag-
nitude for erythrocytes (~fuizels, 1954). In both tissues, there ap-
pears to be no active influx of lithium. However, recently Meltzer, 
Rosoff, Kassir & Fieve. (1976) and Haas, Schooler, & Tosteson. (1975) 
fOlDld that there is an active efflux of lithium from erythrocytes. 
There is some evidence for active transport of lithium in certain epi-
helial membranes. Herrera, Egea, "& Herrera. (1971) demonstrated 
that lithium influx across toad bladder was inhibited by ouabain. 
Since ouabain is an inhibitor of the active sodium transport mecha-
nism, the authors suggested that lithium moves across the bladder, at 
least in part, by the active sodium transport pathway. Zerahn (1955) 
demonstrated that lithium and sodium compete equally well for the 
same transport pathway in frog skin. Furthermore, he established 
that frog skin transports lithium against both electrical and chemi-
cal gradients and concluded that the transport process was active. 
Recently, Candia & Chiarandini (1973) confinued that tmder certain 
conditions lithitmrr is actively transported by frog skin. These work-
ers concluded that lithium ions can both inhibit the sodilDn PlDIlp and 
be actively transported by it. 
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Although the above data indicate that certain epithelial mem-
branes are capable of active lithium transport, there is no indica-
tion that the same is true of the epithelial membrane separating blood 
from c. s. f. and brain tissue. Wright (1972) and Prockop & .Marcus 
(1972) used frog or rabbit choroid plexus incubated in artificial c.s. 
f. containing both lithium and other cations to demonstrate that the 
T:M (tissue:medium) ratio is less than one and that this ratio is com-
patible with lithium movement into the tissue by simple diffusion. 
Prockop & 'Marcus (1972) perfonned ventriculocisternal perfusion stu-
dies in dogs and observed that total lithium clearance could be ac-
cotmted for by bulk flow and simple diffusion. Simultaneously deter-
mined Ii thitml and creatinine clearances were similar. However, these 
studies did not establish the mechanism of lithium entry from blood 
to c.s.f. and vice versa. Thus, the exact mechanisms controlling the 
4 
IOOvement of lithium between blood and c. s. f. are not established. The 
present study was undertaken to elucidate the role of the Choroid 
plexus in regula,ting the c.s.f. concentration of lithitnn with and 
without alterations in c.s.f. and plasma levels of this ion. 
MErnODS and MATERIALS 
Experimental preparation. Adult cats of either sex, body weight 2.5 
to 4.5 kg, were anesthetized with sodium pentobarbital, 30 mg/kg, giv-
en intraperi toneally. A tracheotomy was performed and the animal was 
maintained on artificial respiration throughout the experiment. The 
femoral artery was cannulated for monitoring blood pressure and for 
collecting blood samples. TI1e femoral vein was cannulated to permit 
intravenous administration of supplemental anestt'1etic and infusion of 
154 ~1 (isotonic) LiCI solution. A Harvard lllfusion pump was used to 
infuse the LiCI when constant levels of lithium in plasma were desired. 
Body temperature lvas maintained near 370 C with an electric heating 
pad. A part of the choroid pleXl~ in the left lateral ventricle was 
isolated in a chamber (Fig. I) in situ as described by Miner & Reed 
(1972). In brief, the method requires an extensive unilateral cranio-
tomy, removal of the cerebral cortex overlying the left lateral ven-
tricle and exposure of the plexus within the lateral ventricle. An 
appropriate segment of the plexus is then separated from its underly-
ing connective tissue attachments and isolated within a chamber with 
the blood and nerve supply intact. 
Collection of chamber fluid. After completion of the isolation 
procedure all the fluid in u~e chamber was removed. Fluid secreted 
by the choroid plexus was allowed to collect in the chamber 
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under a layer of liquid petrolatlw that was added to eliminate fluid 
evaporation. In some experiments 50 ~ll of artificial c.s.f. (descri-
bed below) was added to the chamber at the start of the collection 
period. Each collection period was 30 min. An arterial blood sam-
ple (0.5 ml) was obtained at the midpoint of each collection period. 
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Artificial cerebrospinal fluids. The artificial c.s.f. describ-
ed by ~rlis (1940), or with slight modifications, was used in all ex-
periments. The low-lithium and high-lithium fluids were prepared by 
interchanging NaCl and LiCl in the artificial c.sof. so that the final 
lithium concentrations were 1.8 m-equiv/l. or 4.5 m-equiv/l., respec-
tively. 
Analysiss. A protein-free plasma supernatant was prepared by 
adding 4 ml of 0.5 N HN03 to 0.2 ml of plasma which was then centri-
fuged at 3000 r.p.m. Ten ~of chamber fluid or 2 ml of the plasma 
supernatant were diluted 1:1000 or 1:2, respectively, with 0.9% NaCl 
solution for determining the concentration of lithium. Lithium was 
determined with a model 305A Perkin-EImer Atomic Absorption Spectro-
photometer. Protein concentrations were determined by the method of 
Pesce & Strande (1973) on 20 ~l samples of the chamber fluid and a com-
parable volume of a 1:20 dilution of whole plasma. 
Calculations. The concentration of lithium in the newly formed 
c.s.f. was calculated by subtracting the amount of lithium initially 
added to the chamber in the artificial c.s.f. from the total amount in 
the chamber at the end of 30 _min and dividing by the volume of newly 
fonned fluid. The formula used is: 
(X) cf V cf - (X) a Va 
New c. s. f. (X) = ---------
Vef - Va 
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Where eX) is the concentration of the substance in the fluid, V is the 
fluid volume and the subscripts "cf" and "a" refer to chamber fluid 
and added artificial c.s.f., respectively. It is assumed that any 
change in chamber fluid concentration was due to the addition of the 
volume of newly formed fluid of the calculated composition. This as-
sumption may not be absolutely correct but it is not important for the 
purposes of this presentation whether the change in the quantity of 
the substance in the chamber is expressed as a flux or as a concen-
tration in the new fluid. This value will be negative if lithium is 
lost from the chamber. 
Experimental procedure. Three series of experiments were done. 
1. The plasma concentration of lithium was varied by the infusion 
of 154 roM Liel solution. Blood and chamber fluid were collected at 
30 min in tervals . 
2. Artificial c.s.f. that contained lithiurrl was added to the cham-
ber before and after the intravenous infusion of lithium. In all ca-
ses where lithium was infused the plasma lithium concentration was 
maintained higher than that in the chamber. Chamber fluid was removed. 
every 30 min. 
3. Three concentrations of lithium and potassium were added to the 
chamber, namely, lithium:potassium=2.6:1.7; lithium:potassium=S.2:3. 
5; lithium:potassium=IO.2:6.7 m-equiv/l. which provided the same lith-
ium:potassium ratio. Blood lithium was assumed to be negligibly small. 
Chamber fluid was collected every 30 min. 
RESULTS 
The range of fluid accumulation rates in the chamber was 0.6 to 
2. 7 lll/min. The wet weight of the choroid plexus within the chamber 
ranged from 2.2 to 5.6 mg. On the basis of the average rate of fluid 
accumulation and the average wet weight of plexus in the chamber, the 
rate of c.s.f. production by the plexus was about 0.4 to 0.5 lll/min/ 
mg as has been previously reported (Miner & Reed, 1972; Husted & Reed, 
1976; Reed & Yen, 1978). The rate of fluid secretion was unaffected 
by the initial addition of 50 111 of the artificial c.s.f. into the 
chamber. 
The mean protein content of new c.s.f. was 0.69 g/IOO m1 (range 
0.06 to 1.34 g/IOO ml). These protein values are similar to those pre-
viously reported in studies in which the same techniques were used 
(Miner & Reed, 1972, Husted & Reed, 1976). The protein concentration 
of the c.s.f. remained reasonably constant throughout anyone experi-
ment although the first chamber fluid sample often had a slightly high-
er protein content than subsequent ones. 
The relationship of chamber fluid lithium concnetration to that 
in plasma, as measured in the first series of experiment, is shown in 
Fig. 2. Each point on the graph represents the value of one 30-min 
collection of chamber fluid and its corresponding plasma value. Usual-
ly 6 to 8 collections were made from each animal. The range of lith-
ium concentrations in plasma was obtained by infusion of lithium at a 
constant rate into animals of varying weights. The line was calculat-
11 
Fig. 2. The relationship of chamber fluid lithium concentration to that 
in plasma after intravenous infusion of 154 pM LiCl solution. Each 
point represents the value of one 30 min collection of chamber fluid 
and its corresponding plasma level (n=5). The line was calculated 
by linear regression analysis of all the data points and has a slope 

















ed by linear regression analysis of all the data points and has a 
slope of 0.58 : 0.03 (r=O.98). 
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A plot of the ratio of lithium in the chamber fluid to that in 
the plasma as a function of time after the start of the intravenous 
infusion of LiCl is shown in Fig. 3. The c.s.f.-to-plasma ratio var-
ied from O. 53 to 0.60 lv-hen plasma levels ranged from O. 7 to 1.5 m-
equiv/l.; these concentrations are in the therapeutic range in man. 
It is apparent that the c.s.f.-to-plasma ratio is less than one and 
that the ratio remains constant after the first collection period. 
The concentration of lithium in plasma and c.s.f. is plotted 
versus time after the start of an i. v. infusion in Fig. 4. The con-
centration of lithium in plasma and c.s.f. was in a steady state at 
about 90 min. 
The effect of the plasma lithium concentration on the change in 
chamber fluid Ii thitml as measured in the second series of experiments 
is shown in Fig. 5. Two grol~s of experiments were performed. Either 
high-lithium or low-lithium artificial c.s.f. was added to the cham-
ber with no lithium in the plasma or with the plasma lithium main-
tained higher than that in the chamber. The dashed lines represent 
the concentration of lithium in the artificial c.s.f. solutions that 
were added to the chmnber initially. Each point on the graph repre-
sents the mean concentration of lithium in the chamber fluid at the 
end of a 30 min collection period. Usually at least two 30 min col-
lections were obtained from each animal with each added artificial 
c.s.f •. When high (4.5 m-equiv/l.) or low (1.8 rn-equiv/l.) lithium 
artificial c.s.f. '~vas added to the chamber with no lithium in the 
blood, the 1i thium concentration L"'1. the chamber at the end of the 
Fig. 3. The chamber fluid to plasma ratio of lithium as a func-
tion of time after the start of an intravenous infusion of l54rn:tvl 
(isotonic) LiCl solution. The bar for each point represents the 
s .. e.m. (n=5). 
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Fig. 4. The concentration of lithium in plasma and c.s.f. as a func-
tion of time after intravenous infusion of 154 mM (isotonic) Liel solu-
tion. The bar for each point represents the s.e.ID. (n=5). 

















Fig. 5. The effect of the plasma lithium concentration on the change 
in chamber fluid lithitnn. The results of two groups of experiments 
are shown. Either high (4.5 m-equiv/l.) or low (1.8 m-equiv/l.) arti-
ficial c.s.f. was added to the chamber with no lithitnn in the plasma 
or with the plasma lithitnn maintained higher than that in the chamber. 
The dashed lines represent the concentration of lithium in the arti-
ficial c.s.f. that was added to the chamber initially. Each point re-
presents the mean concentration of lithium in the chamber fluid at the 
end of a 30 min collection period. (n=6~. 
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collection period had decreased to 2.6 and·l.0 m-equiv/l., respectively. 
However, when these experiments were repeated with the plasma lithium 
concentration greater than that of the artificial c.s.f. initially, 
the chamber fluid concentration decreased only to 3.5 and 1.7 m-equiv/ 
1., respectively. The change in the total amount of lithium in the 
chamber was calcualted from the data in Fig. 5 and is shown in Fig.6. 
When 50 ~l of low (1.8 m-equiv/l.) or high (4.5 m-equiv/l.) artifi-
cial c.s.f. was added into the chamber, with no lithium in the blood, 
the net change in the amolmt of lithium in the chamber during a 30 
min collection was - 15.2 x 10-6 and - 33.2 x 10-6 m-equiv (columns 
A and C), respectively. The negative values indicate that lithium was 
removed from the chamber fluid during the collection period. In ex-
periments in wnicll the plasma lithium concentration was maintained 
greater than that in the fluid initially added to the chamber, the 
results were 33 x 10-6 and 34.9 x 10-6 m-equiv/l. (columns B and D), 
respectively. 
Three different artificial c.s.f. solutions were used in the 
thrid series of experiments, namely, lithium:potassium=2.6:l.7; lith-
ium:potassium=5.2:3.5; lithium:potassium=10.2:6.7 m-equiv/l. The lith-
ium and potassium concentrations were different but the lithhnn:potas-
sium ratios were the same, and no lithium was infused into the blood. 
The concentration of lithium and potassium in the chamber fluid was 
determined after 30 min. Each solution with a different concentra-
tionoflithium:potassium was added randomly to the chamber in each 
animal. The results are shown in the Table 1. The lithium and potas-
sium concentrations in the chmrrber fluid at the ends of the collection 
periods were significantly different from the initial values when 
21 
Fig. 6. The change in the total amotmt of lithium in the chamber 
after 30 min. Columns A and C represent the net loss of lithium from 
the chamber when the plasma lithium concentration was zero. Columns 
B and D represent the net gain of lithium into the chaTflber fluid when 
the plasma litl1ium concentration was maintained greater than that in 
the chamber. The values were derived from the data in Fig. 5 Cn=6). 
22 
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Table 1. The concentration of lithium and potassium in the chamber fluid initially and after the 30 
min collection periods. 
~~ o MIN 30 MIN IIII 01(1 (initial) (final) x 100% CATION ~ 
'..1>.;: 
0 
Chamber Contc (I) Chamber Contc (II) Li K 
Li:K Li:K 
CONCENTRATION (m-equiv/l) (m-equiv/l) 
Low 2.6 : 1.7 1.6 ± 0.1 : 2.2 t 0.1 61 130 
Meditmt 5.2 : 3.5 2.9 ± 0.2 : 2.8 ~ 0.1 56 80 
High 10.2 : 6.7 5.9 t 0.2 : 4.3 ± 0.2 58 64 
... 
Note: The IIII ratio represents the final concentration of the ion in the chamber fluid as a percent 




either low, medium or high lithium-potassium \vas added (P 0.01). The 
ratio of lithium in the chamber fluid at the end of the 30 min collec-
tion to that in the fluid added to the chamber initially was about the 
same (0.6) with each of the combinations used. However, in contrast 
to lithitnn, the ratio for potassium with low-potassium artificial c. 
s.f. was 1.3; with medium-potassium artificial c.s.f., 0.8; and with 
high-potassium artificial c.s.f., 0.64. 
The total amaunts of lithium in the chamber at the beginning 
and the end of the collection periods are shown in Fig. 7. The total 
amount of lithium in the chanilier decreased after adding the three dif-
ferent concentrations of lithium and potassium in artificial c.s.f.s. 
The magnitude of the decrease is proportional to the concentration 
of the lithium in the artificial c.s.f. added to the chamber. 
25 
Fig. 7. The total amomt of Ii thilDTl in the chamber at the beginning 
and the end of a collection period after adding three different solu-
tion with the same ratio of Ii thilDTl and potassilDTl. The values are 





























The present study was intended to yield evidence about the role 
of the choroid plexus in regulating the lithium concentration in the 
c.s.f. Physiological and pharmacological evidence have demonstrated 
that the choroid plexus plays a major role in electrolyte homeostasis 
and production of c.s.f. It is well established that the composition 
of brain interstitial fluid is close to that of c.s.f. 
In the first series of experiments it was shown that the concen-
tration of lithium in newly formed chamber fluid is less than that in 
plasma after intravenous infusion of LiCl solution. It is apparent 
that the lithium concentration in chamber fluid has a linear correla-
tion with the plasma levels. These data are consistent with the re-
port by Wraae (1978) that a high correlation exists between the steady 
state concentration of lithium in human serum and that in c.s.f. 
The c.s.f. /plasma ratio of 0.58 may be due to at least two 
mechanisms, passive dissusion and/or active transport. If it is as-
sumed that lithium moves passively and freely across the choroid ple-
xus and is in equilibrium with the membrane potential, then the distri-
bution of lithium between blood and c.s.f. may be predicted by the 
Nernst equation. A potential difference of + 2-5 mV between blood 
and c.s.f. (c.s.f. positive) determined by Husted & Reed (1977) using 
the same preparation as in the present study. Calculation of the dis-
tribution of lithium between c.s.f. and plasma with a potential dif-
ference of +2 mV gives a value of 0.93 (93:100) and with a potential 
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difference of +5 mVa value of 0.83 (83:100). The slope of the line 
describing the relationship between lithium in the c.s.f. (chamber 
fluid) and in the plasma is 0.58 (Fig 2). TIlis value is significantly 
different from those predicted above on the basis of purely passive 
distribution of lithium. Assuming that the potential difference across 
the choroid plexus remained within the range of +2-5 mV during the ex-
periments, the data indicate that lithitnn is not in equilibrium with 
the membrane potential. There are two possible explanations for a 
slope of less than one (0.58). If the passive diffusion from blood 
to c.s.f. is slower than the rate of c.s.f. secretion and/or if lith-
ium is actively transported with the secreted fluid via the sodium 
pump but the selectivity for sodium is greater than for lithium, then 
the end result is that the ratio should be less than one. If sodium 
is transported across the choroid plexus into the c.s.f. and assuming 
that there is no selectivity between lithium and sodium by the sodium 
pump, lithium would be expected to appear in the c.s.f. in the same 
proportion to sodium as existed in the plasma. In this case the slope 
of the line in Fig. 2 should have been slightly greater than one yield-
ing a lithium concentration higher in the c.s.f. than in the plasma. 
However, the observed slope is less than one. This suggests that if 
lithium is transported by the sodium pump, it is more selective for 
sodium than for lithium. Keynes & Swan (1959) fOl,md that the rate 
of transport of lithium out of frog muscle is 1/10 to 1/25 that of so-
dium. Given a similar relationship for these ions in the choroid ple-
xus, it follows that the relative amount of lithium pumped into the 
c.s.f. via the sodiun pump by the choroid plexus would be less than 
that of sodium. Also, it is well established that the movement of 
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sodium across the choroid plexus is highly correlated with the forma-
tion of new c.s.f. Thus, the limited tr~lsport of lithium via the so-
dium plllTIp across the choroid plexus could produce c.s.f. with a lith-
ium concentration less than that in plasma and senre to explain a lo-
wer concentration of lithium in the c.s.f. than in the plasma. 
TIlE': concentration of Ii thirnn in newly fonned c. s. f. was main-
tained at 0.53 to 0.60 of the plasma levels as sho,~ in Fig. 3. Seve-
ra] different investigators have reported values for the c.s.f. to 
plasma ratio for lithium, the range varies from 0.25 to 0.67 (Hanlon, 
Romaine, Gilroy & Deitrick, 1949; Schou, Juel-Nielson, Stromgreen & 
Voldby, 1954; Baker & Winokur,. 1966; Platman Rohrlich & Fieve, 1968; 
Gershon, 1970 ; Watanabe , Taguchi, Ebara, Iguchi & Otsuki, 1973. The 
reasons for such a large variation in lithil~ ratios may be related 
to differences in the species studied, the length of the experiments 
(acute or chronic) and in the experimental preparations and tec:hniques. 
The onset action of lithium in the treatment of mania is rela-
tively slow, and a full effect cannot be expected until after 6 to 10 
days of treatment (Anderson & Prockop, 197.5; Baer, 1976; Amdisen, 1977; 
1':iason, Mc Gue en , Keary & James, 1978). The data shmvn in Fig. 4. indi-
cate that lithium reached a steady state III plasma and in c.s.f.in this 
preparation in about 90 min. From these results, it can be inferred 
that the slow onset of action of lithium is not due to its slow rate 
of entry into the C.N.S. It is well established that the c.s.f. is in 
equilibrium with the ECF of brain so it would be expected that lithium 
would reach a therapeutic concentration promptly at the neuron. How-
ever, a much longer time may be required for lithitnTI to produce its 
effect the effect is due to depletion or s)~thesis of the substances 
which ultimately produces the effects attributed to lithil.Jr.l. In any 
case, difficulty in crossing the blood-c.s.f. barrier by lithium ap-
pears entirely inadequate to explain its delayed action. 
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From the data shown in Fig. 5 it can be seen that the concentra-
tion of Ii thiLun in the chamber decreased during the 30 min collection 
periods when either low or high lithium artificial c.s.f. \~as added to 
the chaJImer whether the plasma lithium concentration ·was zero or great-
er than that in the chamber. The lower concentration of lithium in the 
chamber fluid may be explained in two possible ways: 
(lJ lithium was moved out of the chamber either by passive dissusion 
or by active transport. (2) Lithium may have been diluted by newly 
formed fluid with a lower lithium concentration. If it is assumed that 
lithium diffused passively across the choroid plexus, the change L, the 
lithium concentration of the chamber fluid would be expected to be great-
er with a high concentration gradient than with a low one. However, in 
the present study the concentration of lithium in the chamber after the 
30 min collection period was about 45% of that of the low or high-lith-
ium artificial c.s.f. initially added to the chamber when no lithitml 
was present in plasma. However, it is impossible to discolmt complete-
ly any contribution of passive diffusion in this experiment since the 
data in Fig. 6 show that the net loss of lithium from the chamber is 
proportional to the concentration gradient when the plasma concentra-
tion is zero. This implies that a passive diffusion component, though 
small, was present but was obscured by dilution when viewed as a change 
L, concentration in Fig. 5. When the concentration gradient was in the 
opposite direction as also shown in Fig. 6, namely, from plasma to cham-
ber fluid, there was a net gain of lithium in the chamber which was not 
different when low or high lithium was added to the chamber. Superfi-
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cially this may seem inconsistent with the data shown in Fig.5,i.e., 
a decrease in chamber fluid lithium concentration regardless of the 
direction of the gradient. However, when the gradient is from plasma 
to chamber fluid there is a net gain in total lithium in the chamber 
with a concomitant decrease in lithium concentration due to dilution 
of the initial fluid by nelvly formed c.s.f. which decreased the total 
concentration. Total lithium was ulcreased due to the addition of the 
lithium in the newly formed c.s.f. as shown by Fig. 3. On the basis 
of these data it is suggested that the dilution by newly formed fluid 
is major factor in maintaining the low concentration of lithium in the 
chamber with passive diffusion exerting a quantitatively smaller ef-
fect. 
given the amount of lithitnn in the chamber initially as in Fig. 
5, the resultant concentration after 30 min can be closely predicted 
form the data in Fig. 2 which gives the concentration in the newly 
formed c.s.f .. Therefore, it is possible to predict the lithium con-
centration in the charr~er fluid after 30 min when given the plasma 
lithium level and the initial lithium concentration in the chamber 
fluid. 
The third series of experiments was designed to ascertain whether 
lithium was transported by the transport system that regulates potas-
sium. Three different artificial c.s.f. solutions with the same ratio 
of potassium to lithium were added to the chamber. The data in table 
1 show that the change in the concentration of lithium is different 
from that of potassium. Husted & Reed (1976) demonstrated that the 
potassium concentration in c.s.f. is actively regulated by the chor-
oid plexus, which senses the alterations in potassium that OCCU!' in 
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c.s.f.. This was also observed in the present study. The data in Fig. 
7 show that the total amount of lithium in the chamber decreased af-
ter adding the three different concentrations of lithium. The magni-
tude of the decrease was proportional to the concentration gradient 
between chamber fluid and plasma. Thus, passive diffusion and/or ac-
tive transport processes probably serve as the mechanisms involved in 
the regulation of lithium in chamber fluid. The concentration is fur-
ther reduced by dilution with newly formed fluid. Whittam (1962) has 
noted that lithium ion is able to replace both external potassium and 
internal sodium ions and is unlike other alkali metals in that it pos-
sesses the ability to stimulate ATPase activity from both sides of the 
erythrocyte membrane. Beauge (1975) reported that in frog muscle, po-
tassiwn showed a higher affinity than lithium for the pump site. It is 
also demonstrated in the following paper that the rate of 22Na trans-
port from blood to c.s.f. increases after adding lithium into the cham-
ber. This supports the suggestion that lithium is transported across 
the choroid plexus to the blood via the same transport system as potas-
sium however, the data in Table 1 show that the percent change in lith-
ium is the same after the addition of each of the three different con-
centrations of lithium to the chamber. This suggests that the lithium 
contration in c.s.f. is mainly regulated by the newly formed fluid with 
possibly some active transport via a potassium transport system. In 
view of all of the experimental results, it appears that the transport 
of lithium between blood and c.s.f. is by passive diffusion and some 
active transport via the sodium pumps responsible for c.s.f. secretion 
and for sodium-potassium exchange. 
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PART 11«) 
1HE EFFECT OF LITI-IIUM ON ELECTROLYI'E TRA~SPORT BY 
TIlE IN SI111 mOROID PLEXUS OF ruE CAT 
INI'ROOOCfION 
The mechanisms underlying the therapeutic usefulness of lithium 
in mania are not well known. Investigations into the pharmacological 
action of lithium have been in tlvO major areas, biogenic amines and 
electrolytes. A number of factors account for the growing interest 
in electrolyte metabolism in psychiatry. Electrolyte metabolism direc-
tly affects neural activity. Thus, electrolytes such as sodium and 
potassium are known to be essential for the transmission of electrical 
impulses within the nervous system and for the maintenance of resting 
potentials across cell membranes. Electrolyte metabolism may indirect-
ly change brain function through its influence on neurotransmitters 
(Bogdanski & Brodie, 1966; Horst, Kopin, & Ramey, 1968). It is well 
established that ions are involved in many enzymatic processes includ-
ing the storage, release, transport and activation of neurochemical 
modulators. For example, magnesium ions activate maTlY enzyme systems, 
stabilize the organization of macromolecules and chelate many organic 
complexes. 
A similarity of physical and chemical properties among lithium, 
soditnn,. potassium and magnesium has been reported. Li thium has a char-
ge equal to that of sodium or potassium and an ionic radius similar to 
that of magnesium. Schou (1973) has commented that "it is indeed like-
ly that the partial similarity of lithium to these biOlogically impor-
tant cations may accotmt for most of the biochemical and physiological 
effects of lithium salts". Gibbons (1960), Coppen & Shaw (1963); 
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Hull in , Swinscoe, McDonald, & Dransfield, (1968); and Aronoff, Evans 
& Durell., (1971); all reported that sodium excretion increased fol-
lowing the commencement of lithium treatment. Baer, Kassir & Fieve., 
(1970); Ho, Gershon & Pinkney, (1970); and Birch & Jenner (1973) found 
that chronic administration of lithium to rats results in a signifi-
cant decrease in brain sodium concentration. Nielsen (1964) has de-
monstrated that serum magnesium levels are elevated following lithium 
administration to manic patients. Birch & Jenner (1973) observed that 
lithium routinely reduces brain magnesium and significantly increase 
plasma magnesium. Lithium treatment of rats increased both serum and 
urinary magnesium levels (Aronoff, et al., 1971; Andreoli, Villani & 
Brambilla., 1972 and Mellerup, Plenge & Rafaelsen., 1973). Therefore, 
the effect of lithium on the metabolism of electrolytes in the C.N.S. 
may be important in tenus of understanding the action of lithium. 
It is well established that the choroid plexus is a major site 
of c.s.f. production and also participates in regulating the composi-
~ 
tion of the c.s.f .. The in situ isolated choroid pleA~s preparation 
developed by miner & Reed (1972) was used in the present study to in-
vestigate the effect of varying the lithium concentration in plasma 
and in c.s.f. on the concentration of other electrolytes in the c.s.f. 
The results suggest that lithium has potassium-like effects in that it 
stimulates the rate 22Na transport from blood to c.s.f. and of lithium 
from c.s.f. to blood. Lithium may be transported to a llinited extent 
from bleod to c.s.f. via the sodium transport system responsible for 
c.s.f. secretion. 
l 
METHODS and MATERIALS 
The experimental preparation, c.s.f. collection procedures,sam-
pIe analysis and calculations are described in the preceding paper 
(part one). Radioactive 22NaC1 (375 mCi/mg) was purchased from New 
England Nuclear. The rate of infusion was varied as necessary to at-
tain a constant level of 22Na in plasma when that was desired. The 
concentration of lithium and potassium in the chamber fluid was alter-
ed by interchanging .NaCl and LiCl or NaCl and KCl in the artificial 
c.s.f .. The ouabain solution (10-5~M or 10-~) was prepared by adding 
ouabain to the artificial c.s.f. that contained either lithium (1.5 m-
equiv/l.) or potassium (6.6 m-equiv/l.). Magnesium was determined by 
diluting 10 ~l of chamber fluid (1:1000) or one ml of the plasma super-
natant prepared as described in the preceding paDer (1:10) with La-Sr 
solution (1.8 x 10-2M La203 and 1.1 x 10-4M SrC12-6 HZO). Magnesium 
was measured on a model 305 A Perkin-Elmer Atomic Absorption Spectro-
photometer. The radioactivity of Z2Na in plasma and c.s.f. was counted 
with a Nuclear-Chicago liquid-scintillation counter. 
Experimental procedures: Four series of experiments were perfonn-
ed in this study. 
F· . d·' 22N . f d' 1 d lrst experunent: ra 10actlve a was III use mtravenous y an a se-
ries of blood samples and chamber fluid was obtained at 30 min inter-
valse 
Second experiment: LiC1 solution was infused intravenously for 4 hr 
and a steady state concentration of 2Z1'Ja was reached after about 2 hr 
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Blood samples and chamber fluid were removed every 30 min. 
Third experiment:artificial c.s.f. that contaL~ed 1.5 m-equiv/l. of 
LiCl or 6.6 m-equiv/l. of KCl was added to the chamber when a steady-
state concentration of 22Na was ~ttained at 2 hr. 
Fourth experiment:Ouabain (10-\t or 10-\1) was added to the lithium 
(1.5 m-equiv/l.) or potassium (6.6 m-equiv/l.) artificial c.s.f. and 
placed in the chamber when the steady-state for 22Na was attained. 
Chamber fluid was collected every 30 min for 2 hr. 
RESULTS 
The average rate of fluid accumulation and the mean protein con-
centration in the new c.s.f. were similar to those described in the 
preceding paper, namely, 0.35 to 0.47 pl/min/mg tissue and 0.064 to 
1.462 g/IOO mI. 
The effects of lithium infusion on the concentration of magnes-
ium in plasma and chamber fluid are shown in Fig. 8. The concentra-
tion of magnesil~ in plasma was significantly increased (P<O.Ol) when 
the lithium concentration in the plasma was 2.7 m-equiv/l. or more, 
while chamber fluid magnesium was not affected. These results con finn 
the data reported by Nielsen (1964); Mellerup et al., (1973) and Birch 
& Jenner (1973). They are also consistent with the results of a pre-
vious study (Reed & Yen, 1978) of magnesium regulation by the choroid 
plexus in which the plasma magnesium concentration was varied with only 
a small effect on c.s.f. magnesium. 
The ratio of chamber fluid 22Na to plasma 22Na vs. time is shown 
in Fig. 9. The ratio is greater than unity after 90 min. It is well 
established that there is a small concentration gradient for sodium 
between c.s.f. and plasma (Ames, Sakanoue, & Endo, 1964 and Cserr,1975). 
The time course of 22Na content of chamber fluid at 30 min inter-
vals is shown in Fig. 10. The total amotmt of 22Na in the chamber 
fluid was significantly increased from 625 cpm to 1365 cpm when lith-
ium was added to the chamber and from 935 cpm to 1575 cpm with the addi-
tion of potassium (P<O.Ol). There is no difference in 22Na activity 
~ Fig. 8. Effects of lithium infusion on magnesium concentration in 
plasma and c.s.f. Each point on the graph represents the mean value 
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of one 30 min collection of Chamber fluid. The bar for each point 
represents the s.e.m. (n=S) , calculated by Student's t test. *:P< 0.05. 
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Fig. 9. Chamber fluid to plasma ratio of 22Na as a function of time 
after the start of infusion of 22NaCl solution. The bar for each point 
represents the s.e.m., (n=7), calculated by student's t test. * ratios 
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, Fig. 10. Total amol.D1t of 22Na in the chamber fluid vs. time. Start-
ing at the 120 min period 50 ~l of lithit~ (1.5 m-equiv/l.) or high-
potassium (6.6 m-equiv/l.) artificial c.s.f. was added to the chamber. 
Each point on the graph represents the average of 5 animals. Control 
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in the chamber fluid between the controls and the experimental group 
in which 50 lilof nonnal artificial c.s.f. was added to the chamber. 
The rate of c.s. f. secretion does not change when either lithitnn or 
high-potassium is added to the c~amber. 
The effects of potassium and ouabain on 22Na transport are shown 
in Fig. 11. When potassium (6.6 m-equiv/l.) was added to the chamber, 
the rate of 22Na transport from blood to c.s.f. increased from 100 to 
180% of the value at 120 min. However, when ouabain (lO-~O was added 
in combination with potassium the rate of 22Na transport increased 205%. 
Thus, a slight additional stimulation of 22Na transport also occurs 
, when ouabain (10 -~ in addition to high-potasium artificial c. s. f. is 
added. However, 10 - \1 ouabain had a significantly inhibitory effect 
since both 22Na transport from blood to c.s.f. and c.s.f. secretory 
rate are reduced. 
The effects of lithium and ouabain on 22Na transport are summari-
zed in Fig. 12. When lithium (1.5 m-equiv/l.) was added to the chamber, 
the rate of 22Na transport from blood to c.s.f. increased from 100 to 
240% of the value at 120 min and was still increasing after 240 min. 
However, when ouabain (10-5M) was added in combination with lithitnn 
(1.5 m-equiv/l.), the 22Na transport increased only to 180% of the 120 
min value and was maintained at this level throughout the experiment. 
When ouabain was increased to 10-3M the rate of 22Na transport into the 
chamber was significantly inhibited and the rate of c.s.f. secretion 
was reduced (26%). 
The total amount of 22Na in the chamber fluid is plotted as a 
function of time in Fig. 13. The plasma lithium concentration was al-
tered by infusion of Liel solution starting at 120 min. The total 
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Fig. 11. The 22Na content of the chamber fluid expressed as a percent 
of the 120 min value as a function of time. At 120 min high-potassium 
(6.6 m-equiv/l) fluid was added to the chamber with or without ouabain 
(lO-~ or lO-~. Control (0), high-potassium ev), high-potassium + ou-
abain (lO-~4) ee) and high-potassium +ouabain elO-~ eX). Each point 
represents the average of 5 animals. 
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Fig. 12. The 22Na content of the chamber fluid expressed as a percent 
of tile 120 min value as a function of time. At 120 min lithium (1.5 
m-equiv/l.) fluid was added to the chamber with or without ouabain (10 
-~ or 10 -\i). Control (0), lithilUD (6), lithium + ouabain (10-5~O 
ee) and lithium + ouabain (lo-\i) eX). Each point represents the ave-
rage of 5 animals. 
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Fig. 13. The total amount of 22Na in the chamber versus time. LiCl 
(154 ~ was added to the i.v. infusion fluid starting at 120 min. 
Lithium concentration in plasma ranged from 0.06 to 1.07 m-equiv/1. 
Each point represents the average of 4 mlimals. 22Na infusion (0) 
and 22Na + LiCl infusion Ce). 
53 
54 
I'- 0 q ~ 
L() 0 c..o. 
-0 C\I 
.......... N 0 -N ~O CO 
-
::3<.0 0_ go 1Oc: 
'0 -.-E E 
.......... 0 ........... 
~o C\JO) 
....J -E 






o 0 0 00 
o 0 0 0 
~ 0 <.0 (\J 
- -(Wd3) P!nl! JaqwD4~ U! 
IUnOwo ID~Ol ONGG 
55 
amount of 22Na in chamber fluid was not affected by lithium (P>O.05) 
when the plasma lithium level was varied from subtherapeutic to thera-
peutic values in man (0.06 to 1.07 m-equiv/l.). 
DISCUSSION 
Lithium infusion significantly increases plasma magnesium con-
centration. This is consistent with a nl®ber of reports which have 
shown that lithium treatment is accompanied by increased plasma mag-
nesium concentrations (Nielsen, 1964; Bunney, Goodwin, Davis & Fawcett, 
1968; Aronoff et al., 1971; Andreoli, et al., 1972 Birch & Jenner, 
1973; ~~llerup, et al., 1973). Aronoff et ale (1971) reported that 
, the serum magnesium_concentration increased in all but one of their li-
thium-treated patients. These increases were accompanied by elevated 
urinary levels of magneisum. Birch & Jenner (1973) reported that in 
rats lithium apparently leads to a reduction in brain magnesium at the 
same time that plasma magnesilDll levels are increased. In the present 
study the magnesium concentration in chamber fluid was not significant-
ly changed when plasma magnesium was increased by lithium infusion. 
These data confirm the results of Reed & Yen (1978) who reported that 
when the plasma magnesium concentration is varied the chamber fluid 
magnesium remains relatively constant. 
The appearance of 24Na in c.s.f. following its intravenous admi-
nistration has been studied in dogs by Wang (1948), Olsen & Rudolph 
(1955) and Fishman (1959). The rate of exdlange of sodium between 
plasma and c.s.f. varied depending upon the site at which the c.s.f. 
is sampled. Sweet, Selverstone, Solomon & Bakay, (1949) and Davson, 
H. (1958) studied the exchange of 24Na between plasma and the lateral 
ventricle, subarachnoid space, lumbar sac and found that the ventri-
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cular fluid came L~to equilibrium with the plasma much more rapidly 
than did the fluid in the subarachnoid spaces. The authors suggest 
that 2~a probably entered the c. s. f. largely by way of the choroid 
plexuses. The ratio of 22Na L~ c.s.f. to that of plasma shown in Fig. 
9 demonstrates that the radioactive sodiLUn in chamber fluid reaches 
equilibritun. with plasma very rapidly, "which is to be expected since 
the chamber fluid is derived from plasma during the 30 min collection 
period. Also the chamber fluid/plasma ratio of 22Na is larger than 
unity. This indicates a slight concentration gradient of 22Na between 
chamber fluid and plasma. The active transport of sodium across the 
choroid plexus has long been implicated as the drivjng force for c.s.f. 
secretion. To cite one example, Vates, Banting & Oppelt, (1964) found 
a quantitative correlation between the inhibition of c.s.f. formation 
by cardiac glycoside and the activity of the Na-K ATPase in the cho-
roid plexus. This suggests that an active transport process is involv-
ed in maintaining the sodium gradient between c. s. f. and plasma, and 
in c.s.f. secretion. 
The entry of radioactive sodium into the c.s.f. from blood during 
ventriculocisternal perfusion is thought to consist of two components, 
namely, fast and slow (Davson & Pollay, 1963). Davson & Segal (1970) 
suggested that the fast component of entry was probably due to trans-
port directly from blood to c.s.f. across the choroid plexus; the slow 
component was thought to be due to transport from blood to brain and 
thence to c.s.f .• Also, it has been demonstrated that the fast com-
ponent of sodium entry is due to a sodium ptnnp system within the cho-
roid plexus (Davson & Segal, 1970; Wright, 1972). The isolated cho-
reid plexus used in the present studies is uniquely suited for inves-
tigating the fast component of sodium entry without the complicating 
presence of the slow component. On the basis of the observations 
cited above, one would expect that the 22Na in c.s.f. should rapidly 
reach equilibrium with plasma.. This was found to be the case. 
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Large changes in plasma potassium concentration cause relatively 
small alterations in c.s.f. potassium concentration (Bekaert & Demees-
ter, 1951; Domer & Whitcomb, 1964; Bradbury & Davson, 1965; Ames~Iliga­
shi & Nesbett, 1965; Husted & Reed, 1976). It has been demonstrated 
by Husted & Reed (1976) that active transport of potassium from c.s.f. 
to plasma occurs and that the process is under the control of a rnecl1a-
nism that senses c.s.f. potassium concentration. Bradbury & Stulcova 
(1970) and Johanson, Reed & Woodbury, (1974) have found evidence that 
the choroid plexus sodium prnnp is situated at the apical (c.s.f. --
facing) membrane and this hypotllesis is supported by the demonstration 
of ouabain binding to the apical membrane of the frog choroid plexus 
(Quinton, Wright & Tormey, 1973). Recently, Hesketh (1977) reported 
that in incubated choroid plexus of the rabbit the ATPase activity is 
sensitive to the potassium concentration. In the present experiments 
it was shown (Fig. 10) that potassium significantly increases sodium 
entry from blood to c.s.f. when high-potassium artificial c.s.f is pre-
sent on the c.s.f. side. Tllis suggests that the increased sodium entry 
in response to elevated potassium in the chamber fluid is due to acti-
vation of the Na-K exchange pump or perhaps to stimulation of the so-
dium pump responsible for c.s.f. secretion. Although the calculated 
concentration of 22Na in the newly formed fluid is significantly in-
creased, the rate of c.s.f. secretion is not affected when high-pota-
ssium is added to the chamber. This indicates that the increase in 
S9 
22Na in the chamber fluid is not caused by an increase in tile rate of 
fluid production but is due to the stimulation of the Na -K exchange 
transport by the high potassium. Husted & Reed (1976) also found that 
~~e rate of c.s.f. secretion is not changed when potassium concentra-
tion in plasma or c.s.f. is altered. 
Ouabain was l~ed to ascertain whether the stimulatory effect of 
potassium on 22Na entry from blood to c.s.f. was due to stimulation of 
a sodium pump. A dose of ouabain (10 -~1) similar to those used in 
several ventriculocisternal perfusion experiments (Vates et al., 1964; 
Cserr, 1965; Pol lay , 1975), in situ choroid plexus preparations (Welch, 
1963) or in vitro choroid plexus incubation studies (Wright, 1972) was 
used in these experiments. Ouabain (10-~) slightly potentiated in-
stead of inhibiting the stimulatory effect of high-potassium on 22Na 
entry (Fig. 11.) These observations are similar to the data presented 
by Oppelt, patlack & RaIl, (1964) from a ventriculocisternal perfusion 
study, in which a stimulatory effect on c.s.f. production was demons-
trated with a low (10 -8_ l0-l2M) concentration of ouabain. The concen-
tration of ouabain at the site of action L~ the present study may have 
been lower than the concentration in the solution (10 -~ .. 1) and may have 
been as low as the concentration of ouabain (lO-8_l0-l~) used by Oppelt 
(1964). However, when the ouabain concentration of the fluid added to 
the c..~amber was increased from 10-SM to lO-3M, there was a significant 
inhibition of the stimulatory effect of high-potassium on the rate of 
22Na transport form blood to c.s.f. and on the rate of c.s.f. secre-
tion. These inhibitory effects are less than those cited above when 
the same doses were used in both in vitro or in vivo studies. This 
may be due to inadequate stirring of the chamber fluid. The choroi~ 
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plexus is a ciliated epithelium whose cilia beat at a rapid rate. It 
has been postulated that the actions of the cilia are responsible in 
part for circulating or mixing the c.s.f.. In the case of the present 
studies the composition of the layer of c.s.f. adjacent to the choroid 
plexus in the chamber fluid may be significantly different from that 
in the bulk of the chamber fluid if the action of the cilia are inade-
quate to provide good mixing of the dtamber contents with the newly 
secreted fluid. The fact that the choroid plexus is continuously sec-
reting new ouabain free fluid at the cell surface to form a buffer be-
tween the ouabain solution and the cell would also be expected to re-
duce the effectiveness of the ouabain added to the chamber. 
Potassium may interfere with the action of ouabain. Godlman, 
Col tart , Friedman, Nola, Berke, Schweizer & Harrison, (1973) showed 
that hyperkalemia alters the inotropic effects of digoxin by decreasing 
the binding of digoxin by a microsomal cell fraction containing Na-K 
ATPase activity. Akera,Brody, So. Tobin & Baskin, (1974) also pre-
sented evidence that the effects of potassium are consistent with a 
conformational change in the ATPase such that the binding sites for 
ouabain become less accessible. These experiments provide further evi-
dence that a high concentration of potassium in the c.s.f. stimulates 
teh transport of sodium across the choroid plexus by a ouabain-sensi-
tive process. 
Birch & Jenner (1973) showed that lithium in plasma acts to de-
crease the brain sodium concentration and suggested that lithium may 
activate Na-K ATPase at the potassium sensitive site. The data shown 
in Fig. 10 demonstrate that lithium can significantly increase the rate 
of 22Na transport from blood to c.s.f. in a manner si~milar to potass-
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ium when lithium is added directly to the chamber. The calculated 
22Na concentration in the newly fonned fluid was significantly increas-
ed while the rate of c.s.f. secretion was not affected when lithiLnn 
~as present in the chamber. This indicates that the increase in 22Na 
in the chamber fluid is not caused by an increase in the rate of fluid 
production, but rather is due to the lithium stimulating the trans-
22 port of Na from blood to c.s.f .. In vitro and in vivo studies indi-
cate that the passive diffusion of lithium ions resembles that of so-
dium ions and that lithium can substitute for both sodiull and potass-
ium in some active transport mechanisms (Keynes & Swan, 19 S9; McCona-
ghey & ~~izels, 1962). Sjodin & Beauge (1968) suggested that lithium 
ions directly sttffiulate a sodium pump mechanism in skeletal muscle 
that results in increased sodium efflux and in later experiments they 
confirmed this suggestion (Beauge & Ortiz, 1970). Glen, Bradbury, & 
Wilson, (1972) found that 3 ~I lithium stimulates sodium efflux from 
erythrocytes. Confirmation of this finding has come from recent work 
of Hesketh (1977) who reported that ventriculocisternal perfusion stu-
dies in the rabbit show that lithium increased the rate of sodium en-
try into the c.s.f .. Fig. 10 shows tllat lithium significantly increas-
22 
es the rate of Na transport in a manner similar to potassium. Oua-
bain (10 -1vI) significantly inhibits the rate of 22Na entry into the 
c.s.f. as shown in Fig. 12. On the basis of the present studies it 
appears that lithium has an effect similar to that of potassiLnl1 to sti-
mulate the sodium pump. 
Fig. 13. shows that when lithium is administered intravenously 
h · ff 22N t ere 1S no e ect on a transport. These results are different 
from those of Hesketh (1977) who reported that when lithium was pre-
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sent on the blood side there was a marked decrease in the fast compo-
nent of sodium entry. However, Smith & Balagura (1972) fotmd that 
when lithium is administered orally to rats there no effect on sodium 
concentration in the c.s.f. This discrepancy may be due to the dif-
ference in eAperimental preparation and/or species difference. 
Reports in the literature provide strong evidence that active 
sodium pumping produces the osmotic gradient which is responsible for 
c.s.f. production (Diamond, 1965; Diamond & Bossert, 1967; 1968; Segal 
& Pollay, 1977). The present observations show that both lithium and 
an increase in potassium significantly increases the rate of 22Na 
transport from blood to c. s. f., but had no effect on the rate of c. s. f. 
secretion. The fact that in neither case did the rate of c.s.f. sec-
retion increase strongly implies that the sodium pump responsible for 
c.s.f. secretion was not responsible for the increased rate of entry 
of 22Na into the chamber fluid. Since it has been demonstrated pre-
viously in this preparation that potassium is actively removed fr~m the 
c.s.f., probably by an Na-K exchanges mechanism, it seems likely that 
there are fmlctionally two sodium pump transport systems in the cho-
roid plexus that move sodium from blood to c.s.f., one primarily res-
ponsible for c.s.f. secretion and one involved in potassium regulation 
via sodium-potassium exchange. The presence of two sodium pumps in 
other tissues has been postulated by Hoffman & Kregenow (1966) for the 
l~ed blood cell and Whi ttembury & Proverbio (1970) for the renal cortex. 
The presence of two sodilml pumps in the choroid plexus ldould explain 
the results presented in this study. 
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